Related Articles
Sensitivity to chemotherapeutics of NSCLC cells with acquired resistance to EGFR-TKIs is mediated by T790M mutation or epithelial-mesenchymal transition
Epidermal growth factor receptor mutation enhances expression of vascular endothelial growth factor in lung cancer
High efficacy of gefitinib in the treatment of EGFR mutation‑positive advanced non‑small cell lung adenocarcinoma: A case report
Effects of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in EGFR-mutated non-small cell lung cancer
Decreased human antigen R expression confers resistance to tyrosine kinase inhibitors in epidermal growth factor receptor-mutant lung cancer by inhibiting Bim expression